가토에서 버테포르핀을 이용한 각막신생혈관의 광역학치료시 재치료의 효과 = The Effect of Photodynamic Therapy with Verteporfin Retreatment on Corneal Neovascularization in Rabbits

다국어 초록 (Multilingual Abstract)

Purpose: This study evaluated the effect and safety of photodynamic therapy (PDT) with verteporfin retreatment on patients with corneal neovascularization. Methods: Corneal neovascularization was induced with a silk suture of the corneal stroma in 24 white rabbits (48 eyes). Four rabbits were examined histologically before performing PDT. Ten rabbits were chosen randomly, one eye from each rabbit was treated with PDT at 50 J/cm2, and the other eye was used as a control. Both eyes of the remaining 10 rabbits were treated with PDT at 150 J/cm2. One week later, one eye was further retreated with PDT at the same intensity. The area of corneal neovascularization was measured and evaluated histologically using light and electron microscopies. Results: The least neovascularized area was observed in the retreated group (P=0.04). The histologic examination revealed fewer new corneal vessels in the retreated group, but the corneal epithelium, stroma, and endothelium showed a normal appearance. Results from electron microscopic examination demonstrated thrombi as well as destruction and nuclear fragmentation of the vascular endothelial cells. However, there were no other changes in the cornea except for vascular endothelial cells, even in the retreated group. Conclusions: In conclusion, these results suggest that PDT with verteporfin retreatment appears to be safe and significantly more effective in patients with regression of corneal neovascularization. J Korean Ophthalmol Soc 2008;49(9):1515-1524

참고문헌 (Reference)

1 윤경철, "각막신생혈관에서 버테포르핀 광역학치료 2예" 대한안과학회 47 (47): 13-18, 2006

2 Blumenkranz MS, "Verteporfin therapy for subfoveal choroidal neovascularization in age-related macular degeneration: three-year results of an open-label extension of 2 randomized clinical trials-TAP Report no. 5" 120 : 1307-1314, 2002

3 "Verteporfin in photodynamic therapy study group. Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfin 1-year results of a randomized clinical trial-VIP report no.1" 108 : 841-852, 2001

4 Scott LJ, "Verteporfin" 16 : 139-146, 2000

5 Barbazetto IA, "Treatment of choroidal melanoma using photodynamic therapy" 135 : 898-899, 2003

6 Joussen AM, "Topical application of methotrexate for inhibition of corneal angiogenesis" 237 : 920-927, 1999

7 Peyman GA, "The effect of combinations of flubiprofen, low molecular weight heparin, and doxycycline on the inhibition of corneal neovascularization" 25 : 582-585, 2006

8 Shao C, "Suppression of corneal neovascularization by PEDF release from human amniotic membranes" 45 : 1758-1762, 2004

9 Selvasekar CR, "Review article: Photodynamic therapy and the alimentary tract" 15 : 899-915, 2001

10 Corrent G, "Promotion of graft survival by photothrombotic occlusion of corneal neovascularization" 107 : 1501-1506, 1989

11 Gomer CJ, "Preclinical examination of first and second generation photosensitizers used in photodynamic therapy" 54 : 1093-1107, 1991

12 Joussen AM, "Photothrombosis of corneal neovascularization with photosensitizers coupled to macromolecules" 8 : 211-219, 1998

13 Holzer MP, "Photodynamic therapy with verteporfin in a rabbit model of corneal neovacularization" 44 : 2954-2958, 2003

14 Miller JW, "Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: results of a single treatment in a phase 1 and 2 study" 117 : 1161-1173, 1999

15 Schmidt-Erfurth U, "Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: results of a retreatments in a phase 1 and 2 study" 117 : 1177-1187, 1999

16 Parodi MB, "Photodynamic therapy with verteporfin for anterior segment neovascularization in neovascular glaucoma" 138 : 157-158, 2004

17 Fossarello M, "Photodynamic therapy of pterygium with verteporfin" 23 : 330-338, 2004

18 Fossarello M, "Photodynamic therapy of corneal neovascularization with verteporfin" 22 : 485-488, 2003

19 Porrini G, "Photodynamic therapy of circumscribed choroidal haemangioma" 110 : 674-680, 2003

20 Singh AD, "Photodynamic therapy of circumscribed choroidal haemangioma" 88 : 1414-1418, 2004

21 Harding S, "Photodynamic therapy in the treatment subfoveal choroidal neovascularization" 15 : 407-412, 2001

22 Brooks BJ, "Photodynamic therapy for corneal neovascularization and lipid degeneration" 88 : 840-, 2004

23 Primbs GB, "Photodynamic therapy for corneal neovascualrization" 29 : 832-838, 1998

24 Lee P, "Ocular neovascularization: an epidemiologic review" 43 : 245-269, 1998

25 Streilein JW, "New thoughts on the immunology of corneal transplantation" 17 : 943-948, 2003

26 Bressler NM, "Neovascular (Exudative) age-related macular degeneration" Mosby 2005

27 Thompson RW Jr, "Long-term graft survival after penetrating keratoplasty" 110 : 1396-1402, 2003

28 Mendelsohn AD, "Laser photocoagulation of feeder vessels in lipid keratopathy" 17 : 502-508, 1986

29 Murata M, "Inhibitory effect of triamcinolone acetonide on corneal neovascularization" 244 : 205-209, 2006

30 Wu PC, "Inhibition of experimental angiogenesis of cornea by somatostatin" 241 : 63-69, 2003

31 Schmidt-Erfurth U, "In vivo uptake of liposomal benzoporphyrin derivative and photothrombosis in experimental corneal neovascularization" 17 : 178-188, 1995

32 Elner SG, "Human and monkey corneal endothelium expression of low-density lipoprotein receptors" 111 : 84-91, 1991

33 Yoon KC, "Experimental inhibition of corneal neovascularization by photodynamic therapy with verteporfin" 31 : 215-224, 2006

34 Phillips K, "Effects of prednisolone and medroxyprogesterone on corneal wound healing, ulceration, and neovascularization" 101 : 640-643, 1983

35 Pallikaris IG, "Effectiveness of corneal neovascularization photothrombosis using phthalocyanine and a diode laser (675 nm)" 13 : 197-203, 1993

36 Chang JH, "Corneal neovascularization" 12 : 242-249, 2001

37 Nah HJ, "Animal study of photodynamic therapy with verteporfin in corneal neovascualrization" 46 : 707-715, 2005

38 Ambati BK, "Angiostatin inhibits and regresses corneal neovascularization" 120 : 1063-1068, 2002

39 Sickenberg M, "A preliminary study of photodynamic therapy using verteporfin for choroidal neovascularization in pathologic myopia, ocular histoplasmosis syndrome, angioid streaks, and idiopathic causes" 118 : 327-336, 2000